RECENT NEWS
Cytek unveils Aurora Evo flow cytometer
Cytek Biosciences has announced the launch of the Cytek Aurora Evo system, a new full-spectrum flow cytometer that improves on its flagship Cytek Aurora system.
Fujifilm rebrands Life Sciences Group companies
Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses which spans all stages of therapeutic development from discovery through to commercialisation, have announced new names and identities as part of a strategic positioning effort.
New diagnostic tool uses stronger bioluminescence signals to detect viruses
Researchers at US health group Mass General Brigham have developed a novel diagnostic tool which uses bioluminescence to more accurately identify viruses including SARS-CoV-2, HIV, HBV, and HCV in patient samples.
Genomics England supports the development of new AI tool aiding long-read sequencing
Genomics England researchers have played a key role in the development of a new artificial intelligence tool, known as SAVANA, that uses long-read sequencing data to find specific changes within a person’s DNA linked to cancer.
Danaher and AstraZeneca partner to develop precision medicine diagnostics
Danaher has announced the launch of a partnership with AstraZeneca to develop and commercialise novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.
NHS expands use of liquid biopsies for cancer diagnosis
Thousands of NHS patients with lung and breast cancer are to benefit from liquid biopsies, speeding up access to targeted therapy.
Advanced Instruments to acquire and merge with Nova Biomedical
Advanced Instruments has announced a definitive agreement to acquire fellow biotechnology company Nova Biomedical.
SYNLAB wins pathology contact for mid and south Essex
Mid and South Essex NHS Foundation Trust has signed a 15-year contract with private laboratory services provider SYNLAB, for the delivery of a unified pathology service.
UK adopts historic Pandemic Agreement
The British people, the NHS and the economy will be better protected against future global health threats thanks to a new World Health Organization Pandemic Agreement adopted by the UK.
Influenza vaccine prevented around 100,000 hospital admissions
UKHSA data shows the influenza vaccine prevented 96,000 to 120,200 hospitalisations in England during last winter.
Workflow innovation partnership for Mopec Group and Lumea
Anatomic and forensic pathology equipment firm Mopec Group has announced a strategic partnership with Lumea, an innovator in digital pathology and AI-powered workflows.
US partnership in Alzheimer's biomarking
Neurogen Biomarking and Aranscia, a provider of clinical workflow and diagnostic technology, have announced a partnership in which Aranscia's technical and laboratory resources will help to deliver clinical insights and HIPAA-compliant connectivity for the Neurogen Biomarking ecosystem.
Lab Awards open for submission
Entries are now open for the Lab Awards, which provides a platform to formally recognise the achievements of the laboratory community across the UK and Ireland.
Roche partnership aims to accelerate adoption of SBX sequencing
Roche has announced a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology.
Barts Health takes ‘giant step’ for medical research with Sectra
Barts Health NHS Trust has become the first healthcare provider in the NHS to implement Anonymise and Export from medical imaging IT company Sectra, with large volumes of anonymised diagnostic images available to aid ground-breaking research and medical innovations.
Escherichia coli made more virulent by nanoplastics
New research from University of Illinois Urbana-Champaign food scientists suggests certain nanoplastics may make foodborne pathogens more virulent.
New review on statistical and machine learning tools to advance equity in genomic research
A review funded as part of Genomics England’s Diverse Data initiative and led by UCL researchers has outlined how the analytical methods used to process and interpret genomic data play a critical role in promoting health equity.
New study reveals trade-offs to ensure NHS ‘lives within its financial means’
A new study published by health and care charity The King’s Fund uncovers the tough decisions NHS leaders are making to balance their books and protect patient care.
Fujirebio’s IVD test for Alzheimer’s gains FDA clearance
Fujirebio has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse G plasma ratio in vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.
Revvity joins Alderley Park to boost Genomics England collaboration
Life sciences and diagnostics firm Revvity, has chosen Bruntwood SciTech’s Alderley Park as its newest UK hub.
Latest Issues
Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS, to the...
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
Distinguishing tumour tissue from normal tissue
Online
8 July, 2025
Introduction to direct immunofluorescence webinar
Online
10 July, 2025
Annual SHOT Symposium
Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025
Introduction to immunocytochemistry webinar
Online
15-16 July, 2025